Loading…
AS

Ajay Singh

GlaxoSmithKline
Team Leader, Safety Evaluation and Risk Management
Ajay is a nephrologist by training and currently serves as a team leader in the Safety Evaluation and Risk Management group at GSK. The main focus of the group currently is development of oncology/immune-oncology products. Ajay represents GSK on the TransCelerate work stream focused on interpretation of pharmacovigilance guidelines